| Comparing the performance of digital rectal examination and prostate-specific antigen as a screening test for prostate cancer: a systematic review and meta-analysis A Matsukawa, T Yanagisawa, K Bekku, MK Parizi, E Laukhtina, J Klemm, ... European urology oncology 7 (4), 697-704, 2024 | 51 | 2024 |
| Fruit and vegetable intake in relation to prostate cancer in Iranian men: a case-control study F Askari, MK Parizi, M Jessri, B Rashidkhani Asian Pacific journal of cancer prevention 15 (13), 5223-5227, 2014 | 50 | 2014 |
| Occurrence of haemophilia in Iran M Mehdizadeh, M Kardoost, G Zamani, MR Baghaeepour, K Sadeghian, ... Haemophilia 15 (1), 348-351, 2009 | 49 | 2009 |
| Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis K Mori, F Janisch, MK Parizi, H Mostafaei, I Lysenko, DV Enikeev, ... International journal of clinical oncology 25, 247-257, 2020 | 47 | 2020 |
| Prognostic value of variant histology in upper tract urothelial carcinoma treated with nephroureterectomy: a systematic review and meta-analysis K Mori, F Janisch, MK Parizi, H Mostafaei, I Lysenko, S Kimura, ... The Journal of Urology 203 (6), 1075-1084, 2020 | 45 | 2020 |
| Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta … S Kimura, M Abufaraj, F Janisch, T Iwata, MK Parizi, B Foerster, N Fossati, ... Prostate Cancer and Prostatic Diseases 23 (1), 1-10, 2020 | 45 | 2020 |
| Prognostic value of lactate dehydrogenase in metastatic prostate cancer: a systematic review and meta-analysis K Mori, S Kimura, MK Parizi, DV Enikeev, PV Glybochko, V Seebacher, ... Clinical genitourinary cancer 17 (6), 409-418, 2019 | 45 | 2019 |
| Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis M Kardoust Parizi, D Enikeev, PV Glybochko, V Seebacher, F Janisch, ... World Journal of Urology 38, 1437-1449, 2020 | 43 | 2020 |
| Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: a systematic literature review and meta-analysis MK Parizi, M Abufaraj, H Fajkovic, S Kimura, T Iwata, D D'Andrea, ... Urologic Oncology: Seminars and Original Investigations 37 (10), 637-646, 2019 | 43 | 2019 |
| Dietary patterns in relation to prostate cancer in Iranian men: a case-control study F Askari, MK Parizi, M Jessri, B Rashidkhani Asian Pacific Journal of Cancer Prevention 15 (5), 2159-2163, 2014 | 39 | 2014 |
| Increased inflammatory potential of diet is associated with increased risk of prostate cancer in Iranian men N Shivappa, JR Hebert, F Askari, M Kardoust Parizi, B Rashidkhani Int J Vitam Nutr Res 86 (3-4), 161-168, 2016 | 32 | 2016 |
| Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter … K Mori, I Resch, N Miura, E Laukhtina, VM Schuettfort, B Pradere, ... Cancer immunology, immunotherapy 70, 2641-2650, 2021 | 30 | 2021 |
| Supplementary X-ray for ultrasound-guided percutaneous nephrolithotomy in supine position versus standard technique: a randomized controlled trial A Basiri, MA Mirjalili, M Kardoust Parizi, NA Moosa Nejad Urologia Internationalis 90 (4), 399-404, 2013 | 26 | 2013 |
| Management of Zinner’s syndrome associated with contralateral seminal vesicle hypoplasia: a case report M Kardoust Parizi, N Shakhssalim Case reports in urology 2013 (1), 494215, 2013 | 26 | 2013 |
| Fibroblast growth factor receptor: a systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma MK Parizi, V Margulis, Y Lotan, K Mori, SF Shariat Urologic Oncology: Seminars and Original Investigations 39 (7), 409-421, 2021 | 25 | 2021 |
| Autologous fibrin sealant in tubeless percutaneous nephrolithotomy; a prospective study SAM Ziaee, H Abolghasemi, P Eshghi, MH Radfar, A Ahanian, ... Urology journal 10 (3), 999-1003, 2013 | 22 | 2013 |
| Value of tumour‐infiltrating immune cells in predicting response to intravesical BCG in patients with non‐muscle‐invasive bladder cancer: a systematic review and meta‐analysis M Kardoust Parizi, SF Shariat, V Margulis, K Mori, Y Lotan BJU international 127 (6), 617-625, 2021 | 19 | 2021 |
| Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer S Kimura, D D’Andrea, T Iwata, B Foerster, F Janisch, MK Parizi, ... World Journal of Urology 38, 2501-2511, 2020 | 19 | 2020 |
| Serogroup distribution, diversity of exotoxin gene profiles, and phylogenetic grouping of CTX-M-1-producing uropathogenic Escherichia coli SKS Mostafavi, S Najar-Peerayeh, AM Mobarez, MK Parizi Comparative immunology, microbiology and infectious diseases 65, 148-153, 2019 | 19 | 2019 |
| Characterization of uropathogenic E. coli O25b‐B2‐ST131, O15:K52:H1, and CGA: Neutrophils apoptosis, serum bactericidal assay, biofilm formation, and … SKS Mostafavi, S Najar‐Peerayeh, AM Mobarez, MK Parizi Journal of Cellular Physiology 234 (10), 18272-18282, 2019 | 17 | 2019 |
